EDGAR Filing Documents for 0001193125-19-085920

Form 8-K - Current report:

SEC Accession No. 0001193125-19-085920

Filing Date

2019-03-26

Accepted

2019-03-26 07:53:40

Documents

Period of Report

2019-03-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d699950d8k.htm	8-K	23708
2	EX-10.1	d699950dex101.htm	EX-10.1	370944
3	EX-99.1	d699950dex991.htm	EX-99.1	20751
4	EX-99.2	d699950dex992.htm	EX-99.2	17597
5	GRAPHIC	g699950ex99_1s10g1.jpg	GRAPHIC	340912
6	GRAPHIC	g699950ex99_1s11g1.jpg	GRAPHIC	300948
7	GRAPHIC	g699950ex99_1s12g1.jpg	GRAPHIC	404757
8	GRAPHIC	g699950ex99_1s13g1.jpg	GRAPHIC	394714
9	GRAPHIC	g699950ex99_1s14g1.jpg	GRAPHIC	348802
10	GRAPHIC	g699950ex99_1s15g1.jpg	GRAPHIC	359356
11	GRAPHIC	g699950ex99_1s16g1.jpg	GRAPHIC	438097
12	GRAPHIC	g699950ex99_1s17g1.jpg	GRAPHIC	306812
13	GRAPHIC	g699950ex99_1s1g1.jpg	GRAPHIC	246013
14	GRAPHIC	g699950ex99_1s2g1.jpg	GRAPHIC	671419
15	GRAPHIC	g699950ex99_1s3g1.jpg	GRAPHIC	423756
16	GRAPHIC	g699950ex99_1s4g1.jpg	GRAPHIC	388528
17	GRAPHIC	g699950ex99_1s5g1.jpg	GRAPHIC	436653
18	GRAPHIC	g699950ex99_1s6g1.jpg	GRAPHIC	331367
19	GRAPHIC	g699950ex99_1s7g1.jpg	GRAPHIC	397878
20	GRAPHIC	g699950ex99_1s8g1.jpg	GRAPHIC	271293
21	GRAPHIC	g699950ex99_1s9g1.jpg	GRAPHIC	336795
22	GRAPHIC	g699950g0325173743726.jpg	GRAPHIC	4231
	Complete submission text file	0001193125-19-085920.txt		9254481

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421

Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904

Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)